Advertisement
Advertisement
U.S. markets closed
Advertisement
Advertisement
Advertisement
Advertisement

NovaBay Pharmaceuticals, Inc. (NBY)

NYSE American - Nasdaq Real Time Price. Currency in USD
Add to watchlist
0.3419+0.0610 (+21.72%)
At close: 04:00PM EDT
0.3200 -0.02 (-6.41%)
After hours: 07:19PM EDT
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bullishpattern detected
Williams %R

Williams %R

Previous Close0.2809
Open0.2800
Bid0.3102 x 1100
Ask0.3200 x 900
Day's Range0.2801 - 0.3610
52 Week Range0.1700 - 0.7700
Volume6,055,791
Avg. Volume668,267
Market Cap17.99M
Beta (5Y Monthly)2.81
PE Ratio (TTM)N/A
EPS (TTM)-0.1130
Earnings DateAug 11, 2022
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est3.10
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued

Subscribe to Yahoo Finance Plus to view Fair Value for NBY

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • NovaBay Pharmaceuticals, Inc.
    Analyst Report: Pfizer Inc.Pfizer is one of the world's largest pharmaceutical firms, with annual sales close to $50 billion (excluding COVID-19 vaccine sales). While it historically sold many types of healthcare products and chemicals, now, prescription drugs and vaccines account for the majority of sales. Top sellers include pneumococcal vaccine Prevnar 13, cancer drug Ibrance, cardiovascular treatment Eliquis, and immunology drug Xeljanz. Pfizer sells these products globally, with international sales representing close to 50% of its total sales. Within international sales, emerging markets are a major contributor.
    Rating
    Fair Value
    Economic Moat
    7 days agoMorningstar
View more
Advertisement
Advertisement